The combined use of Camellia sinensis and metronomic zoledronic acid in a breast cancer-induced osteolysis mouse model.

CONCLUSIONS: The combination of CS plus metronomic ZOL demonstrated potent anti-tumor, anti-metastasis and anti-osteolysis effects against breast cancer, suggesting the potential clinical application against breast cancer patients.
PMID: 25431338 [PubMed - as supplied by publisher]

Source: Clinical Lung Cancer - November 28, 2014 Category: Cancer & Oncology Authors: Luo KW, Ko CH, Yue GG, Gao S, Lee JK, Li G, Fung KP, Leung PC, Evdokiou A, Lau CB Tags: J Cancer Res Clin Oncol Source Type: research